HeartBeam (BEAT) Invested Capital (2020 - 2021)
HeartBeam's (BEAT) quarterly Invested Capital came in at $13.4 million in Q4 2021, up 2836.73% year-over-year from $456629.6 in Q4 2020, and up 5680.17% quarter-over-quarter from $232000.0 in Q3 2021.
Powered by 
Analysis
HeartBeam (BEAT) Invested Capital (2020 - 2021) Analysis & Trends
HeartBeam (BEAT) has reported Invested Capital for 2 consecutive years, with $13.4 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Invested Capital rose 2836.73% year-over-year to $13.4 million in Q4 2021; TTM through Dec 2021 was $13.4 million, a 2836.73% increase from a year earlier, with the FY2021 full-year figure at $13.4 million, up 2836.73% from the prior year.
- Invested Capital was $13.4 million for Q4 2021 at HeartBeam, up from $232000.0 in the prior quarter.
- Over five years, Invested Capital peaked at $13.4 million in Q4 2021 and troughed at -$490000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 84.37 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 79.00 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 38.93 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 37.80 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 11.32 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 25.74 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 7.50 Bn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 13.41 Mn |
| Sep 30, 2021 | 232,000.00 |
| Dec 31, 2020 | -490,000.00 |